CoChat

Iron-Chelating Therapy

Hershko, Chaim, Weatherall, David J., Finch, Clement · 1988 · CRC Critical Reviews in Clinical Laboratory Sciences

The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.

Abstract

Because of the catalytic action of iron in one-electron redox reactions, it has a key role in the formation of harmful oxygen derivatives and production of peroxidative damage to vital cellular structures. The clinical manifestations of iron overload may be prevented and even reversed by the effective administration of the iron-chelating drug deferoxamine (DF). Recent experimental evidence suggests that DF may also be useful in modifying disease conditions unrelated to iron overload by preventing the formation of free radicals, the powerful final effectors of tissue damage resulting from the respiratory burst of granulocytes and macrophages participating in the inflammatory response. Although much experimental work is still needed, this novel approach in iron-chelating therapy may have far-reaching implications in the management of autoimmune disease, adult respiratory distress syndrome, and organ transplantation. The poor intestinal absorption of DF, its almost prohibitive price, and short duration of action underline the need for new, orally effective iron chelators. A number of very promising orally effective drugs have been identified in recent years, such as the polyanionic amines, aryl hydrazones, and hydroxypyridones. Further development for clinical use of this new generation of iron-chelating drugs is a major challenge for future research.

Overview

Integrity signals

Registry

Crossref · 10.3109/10408368809105894

Cites

242 of 242 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 242 references

Research works printed but not linked: 66

  1. Brown E. B., 1957, J. Lab. Clin. Med., 50, 862
  2. Awai M., 1979, Am. J. Pathol, 95, 663
  3. Editorial, 1985, Lancet, 1, 143
  4. Yamanoi Y., 1982, Acta Haematol. Jpn., 45, 1229
  5. Ganote C. E., 1973, Lab. Invest., 28, 426
  6. Iancu T. C., 1987, Br. J. Exp. Pathol., 68, 53
  7. Hershko C, 1977, Prog. Hemalol., 10, 105
  8. Jacobs A., 1978, Br. J. Exper. Pathol., 59, 489
  9. Link G., 1985, J. Lab. Clin. Med., 106, 147
  10. Yamanoi Y., 1984, Acta Med. Okayama, 38, 423
  11. Awai M., 1982, The Biochemistry and Physiology of Iron, 543
  12. Byers B. R., 1982, The Biochemistry and Physiology of Iron, 179
  13. Sciortino C. V., 1980, J. Lab. Clin. Med., 96, 1081
  14. Cox P. G., 1981, Am. J. Pathol., 102, 151
  15. Hershko C., 1987, J. Lab. Clin. Med., 110, 355
  16. Weatherall D. J., 1981, Thalassaemia Syndromes3rd ed
  17. Hoffbrand A. V, 1980, Iron in Biochemistry and Medicine II, 499
  18. Pippard M. J., 1977, Lancet, 2, 739
  19. Hershko C., 1973, J. Lab. Clin. Med., 81, 876
  20. Cumming R. L. C., 1967, Lancet, 1, 71
  21. Kim B. K., 1985, J. Lab. Clin. Med., 105, 440
  22. Hershko C, 1975, J. Lab. Clin. Med., 85, 913
  23. Hershko C., 1978, J. Lab. Clin. Med., 92, 144
  24. Wagstaff M., 1985, Br. J. Haematol., 61, 566
  25. Waxman H. S., 1969, Prog. Hematol., 6, 338
  26. Pippard M. J., 1978, Clin. Sci. Mol. Med., 54, 99
  27. Anon, 1984, Lancet, 1, 373
  28. 10.1161/01.CIR.30.5.698 · DOI · Paper page
  29. Flynn D. M., 1982, Birth Defects Orig. Art. Ser., 18, 347
  30. Henry W, 1979, Ann. Intern. Med., 91, 892
  31. Heys A. D., 1981, Clin. Sci., 60, 295, 10.1042/cs0600295 · DOI · Paper page
  32. Blake D. R., 1985, Q. J. Med., 56, 345
  33. Arden G. B, Desferrioxamine administered intravenously by infusion causes a loss of retinal sensitivity in rabbits anesthetised with urethane
  34. Gallant T., 1986, N. Engl. J. Med., 314, 1643
  35. Calescibetta C. C., 1986, Am. J. Kidney Dis., 8, A20
  36. Goodill J. J., 1987, N. Engl. J. Med., 317, 54
  37. Polson R. J., 1986, Q. J. Med., 61, 1153
  38. Fligiel S. E. G., 1984, Am. J. Pathol., 115, 375
  39. Weinberg K., 1986, Blood, 68, 286a
  40. Cross C. E., 1985, J. Lab. Clin. Med., 106, 433
  41. Fritch G., 1985, Exp. Pathol., 60, 171
  42. Ramsay C. A., 1974, Q. J. Med., 43, 1
  43. Praga M., 1987, N. Engl. J. Med., 316, 547
  44. Neilands J. B, 1981, Development of Iron Chelators for Clinical Use, 13
  45. Jacobs A, 1981, Development of Iron Chelators for Clinical Use, 39
  46. Grady R. W., 1981, Development of Iron Chelators for Clinical Use, 133
  47. Pitt C. G., 1979, J. Pharmacol. Exp. Ther., 208, 12
  48. Hershko C., 1984, J. Lab. Clin. Med., 103, 337
  49. Gyparaki M., Acta Haematol.
  50. Pitt C. G, 1981, Development of Iron Chelators for Clinical Use, 105
  51. Kontoghiorghes G. J, 1986, Mol. Pharmacol., 30, 670
  52. Grady R. W., 1978, J. Pharmacol. Exp. Ther., 205, 757
  53. Hershko C., 1978, J. Lab. Clin. Med., 92, 144
  54. Grady R. W., 1979, J. Pharmacol. Exp. Ther., 209, 342
  55. Winston A., 1985, J. Pharmacol. Exp. Ther., 232, 644
  56. Peterson C. M., 1979, Exp. Hematol., 7, 74
  57. Harris W. R., 1979, J.C.S. Chem. Commun., 177, 178
  58. Fahey J. L., 1961, J. Lab. Clin. Med., 57, 436
  59. Stifel F. B., 1967, J Anim. Sci., 26, 126
  60. Ponka P., 1970, FEBS Lett., 97, 317
  61. Hershko C., 1981, J. Lab. Clin. Med., 98, 99
  62. Johnson D. K., 1982, J. Pharmacol. Exp. Ther., 221, 399
  63. Brown E. B, 1981, Development of Iron Chelators for Clinical Use, 47
  64. Gyparaki M., 1987, Thalassemia Today. The Mediterranean Experience, 521
  65. Peter H. H, 1983, Schweiz. Med. Wschr., 113, 1428
  66. Pippard M. J., 1986, Scand. J. Haematol., 36, 466, 10.1111/j.1600-0609.1986.tb02282.x · DOI · Paper page

Metadata

Authors
Hershko, C., Weatherall, D. J., & Finch, C.
Affiliations
  • Hebrew University of Jerusalem (IL)
  • University of Oxford (GB)
  • University of Washington (US)
Venue
CRC Critical Reviews in Clinical Laboratory Sciences
Published
1988-01
Volume
26
Issue
4
Pages
303-345
ISSN
0590-8191 (ISSN-L)
OpenAlex
W1997531635
Cited by
141
References
241
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2020: 2 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
0.92
Type
journal article
Language
en
Open access
closed
Locations
  • CRC Critical Reviews in Clinical Laboratory Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (3406-02)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords
iron chelation, deferoxamine, iron overload, free radicals, reactive oxygen species, oxidative stress, respiratory burst, granulocytes, macrophages, autoimmune disease, acute respiratory distress syndrome, organ transplantation, oral iron chelators, arylhydrazones, iron absorption
MeSH terms
Animals, Ascorbic Acid, Deferoxamine, Hemochromatosis, Humans, Iron, Iron Chelating Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron-Chelating Therapy. https://app.cochat.ai/papers/10.3109/10408368809105894
The paper
Hershko, C., Weatherall, D. J., & Finch, C. (1988). Iron-Chelating Therapy. CRC Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408368809105894

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.